Back
Theravance Biopharma, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
TBPH
Theravance Biopharma, Inc.
Last Price:
$19.52
Seasonality Move:
2.25%
7 Day Trial
ALL ACCESS PASS
$
7
Theravance Biopharma, Inc. Stock Forecast
-
Over the next 52 weeks, Theravance Biopharma, Inc. has on average historically risen by 9.9% based on the past 11 years of stock performance.
-
Theravance Biopharma, Inc. has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is Theravance Biopharma, Inc. Stock Undervalued?The current Theravance Biopharma, Inc. [TBPH] share price is $19.53. The Score for TBPH is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
TBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Theravance Biopharma, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Theravance Biopharma, Inc. has on average historically risen by 9.9% based on the past 11 years of stock performance.
Theravance Biopharma, Inc. Stock Rating
Buy
59
Theravance Biopharma, Inc. (TBPH)
is a Buy
Is Theravance Biopharma, Inc. overpriced?
-
Theravance Biopharma, Inc. has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Theravance Biopharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
theravance.com
52-Week Data
52-Week High:
21.03
52-Week Low:
7.90
Prediction Charts
Market Cap:
989.6M
Price in USD:
19.53
Volume:
395K
Beta:
0.73
Technical Analysis
SMA50:
19.11
SMA100:
17.35
SMA200:
14.42
52-Wk Change:
106.01%
Stock Predictions
-
Is Theravance Biopharma, Inc. stock public?Yes, Theravance Biopharma, Inc. is a publicly traded company.
-
What is the Theravance Biopharma, Inc. stock quote today?The Theravance Biopharma, Inc. stock price is 19.53 USD today.
-
How to buy Theravance Biopharma, Inc. stock online?You can buy Theravance Biopharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-27 | 19.78 | 19.82 | 20.02 | 19.58 |
| Jan-28 | 19.76 | 19.03 | 19.93 | 18.83 |
| Jan-29 | 19.18 | 19.18 | 19.61 | 18.96 |
| Jan-30 | 19.03 | 18.94 | 19.32 | 18.78 |
| Feb-2 | 19.12 | 19.83 | 20.02 | 18.99 |
| Feb-3 | 19.91 | 19.99 | 20.16 | 19.56 |
| Feb-4 | 20.01 | 20.09 | 20.24 | 19.88 |
| Feb-5 | 19.84 | 19.58 | 20.50 | 19.47 |
| Feb-6 | 19.57 | 20.48 | 20.49 | 19.00 |
| Feb-9 | 20.51 | 19.50 | 20.60 | 19.35 |
| Feb-10 | 19.49 | 19.40 | 19.69 | 19.20 |
| Feb-11 | 19.49 | 19.51 | 19.71 | 18.45 |
| Feb-12 | 19.69 | 19.40 | 19.69 | 19.09 |
| Feb-13 | 19.49 | 19.53 | 19.93 | 19.32 |
Theravance Biopharma, Inc. Earnings
Theravance Biopharma, Inc. Earnings Report: Per Share Theravance Biopharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Theravance Biopharma, Inc. Forecast Revenue Growth
Theravance Biopharma, Inc. Stock Analysis: Historical quarterly revenues per share for Theravance Biopharma, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.57 per share, and a decrease next year of $1.62 per share.
* Theravance Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.